» Articles » PMID: 12679397

18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2003 Apr 8
PMID 12679397
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Recent reports have indicated the value and limitations of (18)F-FDG PET and (201)Tl SPECT for determination of malignancy. We prospectively assessed and compared the usefulness of these scintigraphic examinations as well as (18)F-FDG PET delayed imaging for the evaluation of thoracic abnormalities.

Methods: Eighty patients with thoracic nodular lesions seen on chest CT images were examined using early and delayed (18)F-FDG PET and (201)Tl-SPECT imaging within 1 wk of each study. The results of (18)F-FDG PET and (201)Tl SPECT were evaluated and compared with the histopathologic diagnosis.

Results: Fifty of the lesions were histologically confirmed to be malignant, whereas 30 were benign. On (18)F-FDG PET, all malignant lesions showed higher standardized uptake value (SUV) levels at 3 than at 1 h, and benign lesions revealed the opposite results. Correlations were seen between (18)F-FDG PET imaging and the degree of cell differentiation in malignant tumors. No significant difference in accuracy was found between (18)F-FDG PET single-time-point imaging and (201)Tl SPECT for the differentiation of malignant and benign thoracic lesions. However, the retention index (RI) of (18)F-FDG PET (RI-SUV) significantly improved the accuracy of thoracic lesion diagnosis. Furthermore, (18)F-FDG PET delayed imaging measuring RI-SUV metastasis was useful for diagnosing nodal involvement and it improved the specificity of mediastinal staging.

Conclusion: No significant difference was found between (18)F-FDG PET single-time-point imaging and (201)Tl SPECT for the differentiation of malignant and benign thoracic lesions. The RI calculated by (18)F-FDG PET delayed imaging provided more accurate diagnoses of lung cancer.

Citing Articles

Comparison of Al[F]-NOTA-FAPI-04 PET/CT and [F]-FDG PET/CT in a patient with lung cancer and pulmonary tuberculosis: a case report and literature review.

Qin J, Yu J, Wei Y Front Oncol. 2025; 15:1470132.

PMID: 39963103 PMC: 11830580. DOI: 10.3389/fonc.2025.1470132.


Value of [F]AlF-NOTA-FAPI-04 PET/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [F]FDG PET/CT.

Qiao K, Qin X, Fu S, Ren J, Jia J, Hu X Eur Radiol. 2023; 34(3):1948-1959.

PMID: 37670186 DOI: 10.1007/s00330-023-10208-y.


Prognostic Value of Dual-Time-Point [F]FDG PET/CT for Predicting Distant Metastasis after Treatment in Patients with Non-Small Cell Lung Cancer.

Lee S, Lee J, Lee J, Jo I, Jang S J Pers Med. 2022; 12(4).

PMID: 35455708 PMC: 9028993. DOI: 10.3390/jpm12040592.


Different Prognostic Values of Dual-Time-Point FDG PET/CT Imaging Features According to Treatment Modality in Patients with Non-Small Cell Lung Cancer.

Jang S, Lee J, Lee J, Jo I, Lee S Tomography. 2022; 8(2):1066-1078.

PMID: 35448721 PMC: 9028882. DOI: 10.3390/tomography8020087.


Current state of oncologic F-FDG PET/CT in Japan: A nationwide survey.

Ichikawa H, Kato T, Miwa K, Shibutani T, Okuda K, Nagaki A Asia Ocean J Nucl Med Biol. 2021; 9(2):158-166.

PMID: 34250144 PMC: 8255529. DOI: 10.22038/AOJNMB.2021.53693.1369.